PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for ...
Read moreA research led by researchers at the Department of Physics of the UAB has managed to emulate learning neuromorphic abilities using thin layers of cobalt oxide. The experiment, performed at the ALBA Sy...
Read moreEl equipo científico de la Universidad Pablo de Olavide dirigido por el doctor José Antonio Sánchez Alcázar continúa avanzando en sus investigaciones sobre la neurodegeneración con acumulación ...
Read moreUn estudio en fase de revisión coliderado por investigadores del Consejo Superior de Investigaciones Científicas (CSIC) ha mostrado cómo actúa el fármaco aplidin (plitidepsina) para inhibir la re...
Read moreCon este análisis se han clarificado los diferentes patrones de evolución tumoral del cáncer de endometrio que podrían tener relevancia en su diseminación metastásica y su comportamiento clínic...
Read moreLa multinacional farmacéutica estadounidense Pfizer, a través de su programa Global Medical Grants, ha seleccionado una investigación del Cima Universidad de Navarra para el estudio de la amiloidos...
Read moreHow does a neural network work? How does it react to a failure? How can you mathematically predicting when it will stop working and what will happen when it does. All these questions have now been ans...
Read moreEl grupo Zendal ha formalizado su apuesta con la start up Innogando, con una primera inversión destinada a la cocreación de dispositivos especializados que mejoran la productividad del ganado. Esta ...
Read moreGlobally, colon cancer is the third most common tumor with nearly 2 million new cases each year. Its incidence is increasing year after year and it is the leading cause of cancer death. Approximately ...
Read morePromoting the fight against the use of drugs of abuse, anticipating to the appearance of new psychoactive drugs and assessing the risks these have on human health are the main objectives of the Europe...
Read moreSpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The fina...
Read moreNina Capital, an emerging specialist venture capital firm, today announced its second fund, started last fall, eclipsed its target size of EUR40 million in just four months. The fund will be used to c...
Read more